Abstracts tagged "spine involvement and spondylarthritis"

Abstract Number: 1894 • 2014 ACR/ARHP Annual Meeting
Is It Worth It to Include MRI of the Spine in the ASAS Classification Criteria for Axial Spondyloarthritis?
Manouk de Hooge¹, Jean-Baptiste Pialat², Antoine Feydy³, Monique Reijnierse¹, Pascal Claudepierre⁴, Alain Saraux⁵, Maxime Dougados³ and Désirée van der Heijde¹, ¹Leiden University Medical Center, Leiden, Netherlands, ²Hôpital Edouard Herriot, Lyon, France, ³Descartes University, Cochin Hospital, Paris, France, ⁴Henri Mondor Teaching Hospital, Creteil, France, ⁵CHU de la Cavale Blanche, Brest Cedex, France
Background/Purpose: Spinal MRI lesions suggestive of axial Spondyloarthritis (axSpA) are not included in the ASAS definition of a positive MRI, but do occur in the…
Abstract Number: 1187 • 2014 ACR/ARHP Annual Meeting
Scoring of Spinal Lesions Compatible with Axial Spondyloarthritis on MRI in Clinical Practice By Local Radiologist or Rheumatologist in Desir; Comparison with Central Reading
Manouk de Hooge¹, Jean-Baptiste Pialat², Monique Reijnierse¹, Désirée van der Heijde¹, Pascal Claudepierre³, Alain Saraux⁴, Maxime Dougados⁵ and Antoine Feydy⁵, ¹Leiden University Medical Center, Leiden, Netherlands, ²Hôpital Edouard Herriot, Lyon, France, ³Henri Mondor Teaching Hospital, Creteil, France, ⁴CHU Brest and EA 2216, UBO, Brest, France, ⁵Descartes University, Cochin Hospital, Paris, France
Background/Purpose: In clinical practice radiologists and rheumatologists assess whether lesions compatible with axial SpondyloArthritis (axSpA) are present on spinal MRI. The objective was to compare…
Abstract Number: 1186 • 2014 ACR/ARHP Annual Meeting
Prevalence of MRI Spinal Lesions Typical for Axial Spondyloarthritis in Patients with Inflammatory Back Pain
Manouk de Hooge¹, Jean-Baptiste Pialat², Antoine Feydy³, Monique Reijnierse¹, Pascal Claudepierre⁴, Alain Saraux⁵, Maxime Dougados³ and Désirée van der Heijde¹, ¹Leiden University Medical Center, Leiden, Netherlands, ²Hôpital Edouard Herriot, Lyon, France, ³Descartes University, Cochin Hospital, Paris, France, ⁴Henri Mondor Teaching Hospital, Creteil, France, ⁵CHU de la Cavale Blanche, Brest Cedex, France
Background/Purpose: A cut-off value of ³3 inflammatory lesions was suggested by the ASAS/OMERACT group, as positive MRI of the spine (MRI-spine). Moreover, fatty lesions on…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].